SUBSCRIBE
SUBSCRIBE

Pain

Pictured: Falling Pain Pill Bottles / Taylor Tiede
Latigo Launches into Non-Opioid Pain Medicine Space with $135 Million Series A
Two weeks after Vertex’s Phase III data for VX-548 reenergized the field, Latigo Biotherapeutics announced $135 million in Series A funds to push its own NaV1.8 inhibitor into Phase II.
February 13, 2024
 · 
3 min read
 · 
Heather McKenzie
Load More
PRESS RELEASES
Press Releases
Vertex Announces New Drug Submission for Suzetrigine Has Been Accepted for Review by Health Canada for the Treatment of Moderate-to-Severe Acute Pain in Adults
May 21, 2026
 · 
4 min read
Press Releases
Medtronic announces intent to acquire SPR Therapeutics, Inc., expanding care options for people living with chronic pain
May 20, 2026
 · 
4 min read
Press Releases
AlzeCure Pharma to Host Live Seminar on The Pain Project TrkA-NAM ACD137 with a Focus on Osteoarthritis and Neuropathic Pain
May 19, 2026
 · 
4 min read
Press Releases
Dogwood Therapeutics Announces Commencement of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b Long Term Extension Study
May 18, 2026
 · 
5 min read
Press Releases
Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation
May 18, 2026
 · 
3 min read
Press Releases
U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain
May 18, 2026
 · 
9 min read
Press Releases
MEDIPOST’s CARTISTEM® Meets All Primary and Secondary Endpoints in Japan Phase 3 Trial and Demonstrates Statistically Significant Efficacy Gains Versus Active Control
May 14, 2026
 · 
4 min read
Press Releases
Renerva Achieves First-in-Human Implant of PNM-CAP™ Device for Neuroma Pain
May 13, 2026
 · 
3 min read
Press Releases
Ensysce Biosciences CEO Presents at Inaugural Clinical Pain Symposium in Amsterdam
May 8, 2026
 · 
4 min read
Press Releases
BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease
May 8, 2026
 · 
8 min read
Press Releases
New scientific Article Published on TrkA-NAM ACD137 Against Osteoarthritic Pain
May 6, 2026
 · 
4 min read
Press Releases
Quiver Bioscience Receives NIH HEAL Initiative Award to Advance Nav1.7 Antisense Therapy for Chronic Pain Through Early Clinical Trials
May 4, 2026
 · 
5 min read
Press Releases
Contineum Therapeutics Reports Positive Topline Data From Its Exploratory PIPE-791 Phase 1b Trial in Chronic Pain
May 1, 2026
 · 
9 min read
Press Releases
Confo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate, CFTX-1554
April 30, 2026
 · 
3 min read
Press Releases
Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation
April 29, 2026
 · 
3 min read
Press Releases
Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain
April 29, 2026
 · 
9 min read
Press Releases
Real-World Data on EXPAREL® Shows Reduced Opioid Use and Lower Total Medical Costs in Medicare Patients Undergoing Total Hip Arthroplasty
April 27, 2026
 · 
10 min read
Press Releases
Autonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026
April 23, 2026
 · 
3 min read
Press Releases
New data for Smith+Nephew’s CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant demonstrates superior pain relief and functional gains at 5-years
April 21, 2026
 · 
7 min read
Press Releases
Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile
April 20, 2026
 · 
4 min read
Load More